Elena is a Research Fellow at CHERE. She has a BSc in Economics and Law from University of Utrecht and a MSc in Health Economics, Policy and Law from Erasmus University Rotterdam (The Netherlands). She has experience and interest in health technology assessment, health policy analysis, and discrete choice methods, in particular, conducting discrete choice experiments (DCEs).
McCarthy, M, De Abreu Lourenco, R, McMillan, LJ & Meshcheriakova, O 2020, 'Finding out what matters in decision-making related to genomics and personalized medicine in pediatric oncology: Developing attributes to include in a discrete choice experiment', The Patient: Patient Centered Outcomes Research.View/Download from: Publisher's site
Saing, S, Haywood, P, van der Linden, N, Manipis, K, Goodall, S & Meshcheriakova, O 2019, 'Real-World Cost Effectiveness of Mandatory Folic Acid Fortification of Bread-Making Flour in Australia.', Applied health economics and health policy, vol. 17, no. 2, pp. 243-254.View/Download from: Publisher's site
BACKGROUND:In 2009, mandatory folic acid fortification of bread-making flour was introduced in Australia to reduce the birth prevalence of preventable neural tube defects (NTDs) such as spina bifida. Before the introduction of the policy, modelling predicted a reduction of 14-49 NTDs each year. OBJECTIVE:Using real-world data, this study provides the first ex-post evaluation of the cost effectiveness of mandatory folic acid fortification of bread-making flour in Australia. METHODS:We developed a decision tree model to compare different fortification strategies and used registry data to quantify the change in NTD rates due to the policy. We adopted a societal perspective that included costs to industry and government as well as healthcare and broader societal costs. RESULTS:We found 32 fewer NTDs per year in the post-mandatory folic acid fortification period. Mandatory folic acid fortification improved health outcomes and was highly cost effective because of the low intervention cost. The policy demonstrated improved equity in outcomes, particularly in birth prevalence of NTDs in births from teenage and indigenous mothers. CONCLUSIONS:This study calculated the value of mandatory folic acid fortification using real-world registry data and demonstrated that the attained benefit was comparable to the modelled expected benefits. Mandatory folic acid fortification (in addition to policies including advice on supplementation and education) improved equity in certain populations and was effective and highly cost effective for the Australian population.
Meshcheriakova, O, Goodall, S, Street, D & Viney, R 2019, 'Does the price premium for branded medicines reflect preferences? A case study from Australia', 11th Meeting of the International Academy of Health Preference Research, Auckland, New Zealand.
Saing, S, Haywood, P, Van Der Linden, N, Manipis, K, Meshcheriakova, O & Goodall, S 2019, 'Real world cost-effectiveness of mandatory folic acid fortification of bread making flour in Australia', 11th Health Services and Policy Research Conference, Auckland, New Zealand.
Mulhern, B, Norman, R, Street, D, Lancsar, E, Ratcliffe, J, Shah, K, Devlin, N, Meshcheriakova, O, Saing, S, Manipis, K, Addo, R, Nolasco, V, Brazier, J & Viney, R 2019, 'Valuing EQ-5D-5L: comparing the time trade off and discrete choice experiment valuation methods', 11th Meeting of the International Academy of Health Presference Research, Auckland, New Zealand.
Flattery, M, Mulhern, B, Norman, R, Viney, R, Street, D, Feng, Y, Addo, R, Manipis, K, Meshcheriakova, O & Saing, S 2017, 'Valuing EQ-5D-5L in Australia using an adapted EQ-VT: Informing the further development of a revised valuation protocol', 34th EuroQol Plenary Meeting, Barcelona.